CosmEthics Revenue and Competitors
Estimated Revenue & Valuation
- CosmEthics's estimated annual revenue is currently $840k per year.
- CosmEthics's estimated revenue per employee is $84,000
Employee Data
- CosmEthics has 10 Employees.
- CosmEthics grew their employee count by 0% last year.
CosmEthics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO, founder | Reveal Email/Phone |
CosmEthics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $12.6M | 90 | -36% | $14.1M | N/A |
#2 | $83.2M | 468 | -3% | $251M | N/A |
#3 | $14M | 100 | 1% | N/A | N/A |
#4 | $14.6M | 0 | N/A | $12.5M | N/A |
#5 | $30.3M | 197 | -6% | N/A | N/A |
#6 | $0.1M | 6 | -25% | $2.6M | N/A |
#7 | $45.1M | 293 | 2% | N/A | N/A |
#8 | $4.8M | 43 | -7% | N/A | N/A |
#9 | $399.3M | 2037 | 40% | N/A | N/A |
#10 | $44M | 286 | 4% | N/A | N/A |
What Is CosmEthics?
CosmEthics educates consumers about cosmetic ingredient safety, and suggests healthy alternative products by referencing medical research data. Consumers have very few methods to determine if a product is safe. The CosmEthics app allows users to scan the product's bar code, and cross-references it with undesirable ingredients or allergens. Thus users can quickly assess the product's health hazards, with a toxicity screening of INCI ingredients.
keywords:N/A
N/A
Total Funding
10
Number of Employees
$840k
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CosmEthics News
... Yuka, CosmEthics, Ingred, No-Grab, MeiLiXiuXing, Chemical Maze, SkinSafe, CosDNA, Skin Bliss & Cosmetic Ingredient Review.
CosmEthics; Ingred; No-Grab; MeiLiXiuXing; Chemical Maze; SkinSafe; CosDNA; Skin Bliss; Cosmetic Ingredient Review. The research covers the...
Other Companies in Helsinki
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1.2M | 10 | -33% | N/A |
#2 | $1M | 10 | 0% | N/A |
#3 | $0.9M | 10 | -9% | N/A |
#4 | N/A | 10 | 11% | N/A |
#5 | $0.9M | 10 | 0% | N/A |